Monitor for any subsequent pricing or prospectus filing (e.g., 424B4/424B3) to see actual terms and dilution impact. The S-4 effectiveness enables the company to proceed with a business combination or exchange offer, but no deal value or exchange ratio is provided here.
Price Chart
Executive Summary
Bio Green Med Solution, Inc. received SEC effectiveness for its S-4 registration (File No. 333-296815) on October 8, 2026. This allows the company to complete a business combination or exchange offer, creating potential dilution overhang. The filing is routine for a small-cap issuer with no disclosed financial details.
Key Facts
- Effectiveness date: October 8, 2026
- File Number: 333-296815
- Form type: S-4 (business combination or exchange offer)
- Issuer: Bio Green Med Solution, Inc. (formerly Cyclacel Pharmaceuticals, Inc.)
- No pricing, share count or dollar amount disclosed in the filing
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- Potential dilution if shares are issued in the business combination
- No disclosed financials or guidance in this filing
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003182 |
| Document: 9999999995-26-003182-index.html | 9999999995-26-003182 |
| Document: 9999999995-26-003182.txt | 9999999995-26-003182 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | S-3 | $0.9050 | awaiting T+20 | — | $0.9748 (−7.71%) |
Oct 16, 2026 9d ago | 8-K | $0.9329 | awaiting T+20 | — | $0.9748 (+4.49%) |
Oct 9, 2026 17d ago | EFFECT | $0.8490 | awaiting T+20 | — | $0.9748 (+14.82%) |
Aug 13, 2026 10w ago | 8-K | $0.9150 $0.8976 | ▲ +1.90% | ▼ −0.09% | $0.9748 (−6.54%) |
Jul 24, 2026 13w ago | S-4/A | $0.9249 $0.8705 | ▲ +5.88% | ▲ +9.18% | $0.9748 (−5.40%) |
Jun 4, 2026 20w ago | Press Release | $1.50 $0.9398 | ▼ −37.35% | ▼ −39.21% | $0.9748 (−35.01%) |
Mar 30, 2026 29w ago | Press Release | $1.00 $0.9600 | ▼ −4.00% | ▼ −13.42% | $0.9748 (−2.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers